CDKN2A and neoplasm: Considering the tumor’s p16-status, the highest survival estimates were observed in never smoking patients with p16-positive tumors, whereas patients with p16-positive disease and a history of smoking had a comparable inferior prognosis like p16-negative tumors of former or current smokers.